Clinical trial of two antivenoms for the treatmentof Bothrops and Lachesis bites in the northeastern Amazon region of Brazil

Pardal, Pedro Pereira de Oliveira; Souza, Suzana Medeiro; Monteiro, Maria Rita de Cássia da Costa; Fan, Hui Wen; Cardoso, João Luiz Costa; França, Francisco Oscar Siqueira; Tomy, Sandra Corrallo; Sano Martins, Ida S; Sousa e Silva, Maria Cristina Cirillo de; Colombini, Mônica; Kodera, Nancy F; Silva, Ana Maria Moura da; Cardoso, Diva Ferreira; Velarde, David Toledo; Kamiguti, Aura S; Theakston, Robert David G; Warrell, David A.
Trans. R. Soc. Trop. Med. Hyg ; 98(1): 28-42, 2004.
Artículo en Inglés | SES-SP, SESSP-IBPROD, SES-SP, SESSP-IBACERVO | ID: biblio-1068294

Documentos relacionados

  1. Harnessing the Cross-Neutralisation Potential of Existing Antivenoms for Mitigating the Outcomes of Snakebite in Sub-Saharan Africa.
  2. Type I ABO discrepancy due to missing antibody attributable to anti-snake venom in two patients: A rare presentation.
  3. A current perspective on snake venom composition and constituent protein families.
  4. Benefits of Sebastiania hispida (Euphorbiaceae) extract and photobiomodulation therapy as potentially adjunctive strategies to be explored against snake envenoming.
  5. Rural Set Up Experience of Viper Bite Treatment with Special Reference to FFP in Venom Induced Consumption Coagulopathy.
  6. Expanding donor pool by utilizing deceased donors with snake envenoming.
  7. Snakebites: reducing their international impact.
  8. Anti-snake Venom (ASV) Intradermal Skin Test, a Common Clinical Practice in the Primary Health Care Setting in Tribal Block of Dahanu, Maharashtra, India.
  9. Improving  <i>in vivo</i> assays in snake venom and antivenom research: A community discussion.
  10. Global parameter optimisation and sensitivity analysis of antivenom pharmacokinetics and pharmacodynamics.